Ovarian Endometrioid Adenocarcinoma Suspended Phase 1 / 2 Trials for Entinostat (DB11841)

IndicationStatusPhase
DBCOND0028505 (Ovarian Endometrioid Adenocarcinoma)Suspended1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs